Aim: This study evaluated the overall survival (OS) of older patients (≥60 years) with acute myeloid leukemia based on the intensity of treatment. Methods: This single center, retrospective study included 211 patients diagnosed between 2000 and 2016, who received 10-day decitabine, low-intensity therapy or high-intensity therapy. Cox regression examined the impact of therapy on OS. Results: Younger patients were more likely to receive high-intensity therapy. Patients who received low-intensity therapy had worse OS compared with high-intensity therapy (median OS: 1.2 vs 8.5 months; p < 0.01). OS was similar with 10-day decitabine (median OS of 6.3 months) compared with either low-intensity therapy or high-intensity therapy. Conclusion: Ten-day decitabine is an effective alternative in older patients with newly diagnosed acute myeloid leukemia.
Aim: This study evaluated the overall survival (OS) of older patients (≥60 years) with acute myeloid leukemia based on the intensity of treatment. Methods: This single center, retrospective study included 211 patients diagnosed between 2000 and 2016, who received 10-day decitabine, low-intensity therapy or high-intensity therapy. Cox regression examined the impact of therapy on OS. Results: Younger patients were more likely to receive high-intensity therapy. Patients who received low-intensity therapy had worse OS compared with high-intensity therapy (median OS: 1.2 vs 8.5 months; p < 0.01). OS was similar with 10-day decitabine (median OS of 6.3 months) compared with either low-intensity therapy or high-intensity therapy. Conclusion: Ten-day decitabine is an effective alternative in older patients with newly diagnosed acute myeloid leukemia.
Authors: William Blum; Rebecca B Klisovic; Bjoern Hackanson; Zhongfa Liu; Shujun Liu; Hollie Devine; Tamara Vukosavljevic; Lenguyen Huynh; Gerard Lozanski; Cheryl Kefauver; Christoph Plass; Steven M Devine; Nyla A Heerema; Anthony Murgo; Kenneth K Chan; Michael R Grever; John C Byrd; Guido Marcucci Journal: J Clin Oncol Date: 2007-08-06 Impact factor: 44.544
Authors: Mazin Al-Salihi; Margaret Yu; David M Burnett; Amanda Alexander; Wolfram E Samlowski; Frank A Fitzpatrick Journal: Epigenetics Date: 2011-08-01 Impact factor: 4.528
Authors: William Blum; Ramiro Garzon; Rebecca B Klisovic; Sebastian Schwind; Alison Walker; Susan Geyer; Shujun Liu; Violaine Havelange; Heiko Becker; Larry Schaaf; Jon Mickle; Hollie Devine; Cheryl Kefauver; Steven M Devine; Kenneth K Chan; Nyla A Heerema; Clara D Bloomfield; Michael R Grever; John C Byrd; Miguel Villalona-Calero; Carlo M Croce; Guido Marcucci Journal: Proc Natl Acad Sci U S A Date: 2010-04-05 Impact factor: 11.205
Authors: Michael Lübbert; Björn H Rüter; Rainer Claus; Claudia Schmoor; Mathias Schmid; Ulrich Germing; Andrea Kuendgen; Volker Rethwisch; Arnold Ganser; Uwe Platzbecker; Oliver Galm; Wolfram Brugger; Gerhard Heil; Björn Hackanson; Barbara Deschler; Konstanze Döhner; Anne Hagemeijer; Pierre W Wijermans; Hartmut Döhner Journal: Haematologica Date: 2011-11-04 Impact factor: 9.941
Authors: Frederick R Appelbaum; Holly Gundacker; David R Head; Marilyn L Slovak; Cheryl L Willman; John E Godwin; Jeanne E Anderson; Stephen H Petersdorf Journal: Blood Date: 2006-02-02 Impact factor: 22.113
Authors: Gunnar Juliusson; Petar Antunovic; Asa Derolf; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Ulf Tidefelt; Anders Wahlin; Martin Höglund Journal: Blood Date: 2008-11-13 Impact factor: 22.113
Authors: Vijaya R Bhatt; Valerie Shostrom; Sarah A Holstein; Zaid S Al-Kadhimi; Lori J Maness; Ann Berger; James O Armitage; Krishna Gundabolu Journal: Clin Lymphoma Myeloma Leuk Date: 2020-02-04
Authors: Ian M Bouligny; Vivek Mehta; Scott Isom; Leslie R Ellis; Rupali R Bhave; Dianna S Howard; Susan Lyerly; Megan Manuel; Sarah Dralle; Bayard L Powell; Timothy S Pardee Journal: Leuk Res Date: 2021-02-12 Impact factor: 3.156
Authors: Yaping Chang; Gordon H Guyatt; Trevor Teich; Jamie L Dawdy; Shaneela Shahid; Jessica K Altman; Richard M Stone; Mikkael A Sekeres; Sudipto Mukherjee; Thomas W LeBlanc; Gregory A Abel; Christopher S Hourigan; Mark R Litzow; Laura C Michaelis; Shabbir M H Alibhai; Pinkal Desai; Rena Buckstein; Janet MacEachern; Romina Brignardello-Petersen Journal: PLoS One Date: 2021-03-30 Impact factor: 3.240